Related Experiment Video
Updated: Jul 14, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
3.9K
Mitral bioprosthesis early dysfunction treated with transapical valvuloplasty during V-A ECMO
Antonio D'Errico Ramirez1, Vito Giovanni Ruggieri1,2
1Division of Thoracic and Cardiovascular Surgery, CHU Reims, Reims, France.
Perfusion
|June 17, 2024
Summary
A 61-year-old male experienced early mitral valve bioprosthesis thrombosis after surgery, requiring VA ECMO. Transapical balloon valvuloplasty successfully restored leaflet mobility, resolving the complication.
Area of Science:
- Cardiovascular Surgery
- Interventional Cardiology
- Biomedical Engineering
Background:
- Mitral valve bioprosthesis implantation is a critical cardiac procedure.
- Post-cardiotomy shock can necessitate mechanical circulatory support, such as VA ECMO.
- Early bioprosthetic valve failure, particularly due to thrombosis, poses a significant clinical challenge.
Observation:
- A 61-year-old male developed post-cardiotomy shock following mitral valve bioprosthesis replacement.
- The patient required venoarterial extracorporeal membrane oxygenation (VA ECMO) support.
- Early thrombosis led to bioprosthetic mitral valve failure, indicated by impaired leaflet mobility.
Findings:
- Transapical balloon valvuloplasty was performed as a treatment for the thrombosed mitral valve bioprosthesis.
- The valvuloplasty procedure successfully restored normal leaflet mobility of the bioprosthetic valve.
- This intervention effectively addressed the early bioprosthetic valve failure.
Implications:
- Transapical balloon valvuloplasty is a viable option for managing early mitral valve bioprosthesis thrombosis.
- Successful intervention can prevent the need for reoperation in select cases.
- This case highlights the importance of timely diagnosis and minimally invasive treatment for bioprosthetic valve complications.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...